Hsiao Kuang-Hung, Huang Chun-Ming, Lee Yu-Hsiang
Department of Biomedical Sciences and Engineering, National Central University. No. 300, Jhongda Rd., Taoyuan City 32001, Taiwan.
Department of Dermatology, University of California, San Diego, CA 92093, USA.
Nanomaterials (Basel). 2020 Jun 1;10(6):1095. doi: 10.3390/nano10061095.
Acne vulgaris is one of the most prevalent dermatological diseases among adolescents and is often associated with overgrowth of () in the pilosebaceous units. In this study, we aimed to develop novel rifampicin (RIF) and indocyanine green (ICG) co-loaded perfluorocarbon nanodroplets named RIPNDs which can simultaneously provide photo-, chemo-, and probiotic-antimicrobility, and explore their efficacy in treatment of and . The RIPNDs were first characterized as being spherical in shape, with a size of 238.6 ± 7.51 nm and surface charge of -22.3 ± 3.5 mV. Then, the optimal dosages of -produced fermentation product medium (FPM) and RIPND were determined as 25% (/) and [RIF]/[ICG] = 3.8/20 μM, respectively, based on the analyses of inhibition zone and cytotoxicity . Through the study using -inoculated mice, our data showed that the group treated with FPM followed by RIPNDs + near infrared (NIR) irradiation obtained the least granulocytes/macrophage-inflammatory protein 2 expression level in the epidermis, and showed a significantly lower microbial colony population compared to the groups treated with equal amount of RIF, FPM, RIPNDs, and/or combination of the above ± NIR. These results indicated that the RIPND-mediated photo-chemo-probiotic therapeutics was indeed able to rapidly suppress inflammatory response of the skin and provide a robust antibacterial effect against with limited use of antibiotics. Taken altogether, we anticipate that the RIPND is highly potential for use in the clinical treatment of acne vulgaris.
寻常痤疮是青少年中最常见的皮肤病之一,通常与皮脂腺单位中()过度生长有关。在本研究中,我们旨在开发新型的负载利福平(RIF)和吲哚菁绿(ICG)的全氟碳纳米液滴,即RIPNDs,其可同时提供光、化学和益生菌抗菌性能,并探索它们在治疗()和()方面的疗效。RIPNDs首先被表征为球形,尺寸为238.6±7.51nm,表面电荷为-22.3±3.5mV。然后,基于抑菌圈和细胞毒性分析,确定()产生的发酵产物培养基(FPM)和RIPNDs的最佳剂量分别为25%(/)和[RIF]/[ICG]=3.8/20μM。通过使用()接种小鼠的研究,我们的数据表明,先用FPM治疗,然后用RIPNDs+近红外(NIR)照射的组在表皮中获得的粒细胞/巨噬细胞炎性蛋白2表达水平最低,并且与用等量的RIF、FPM、RIPNDs和/或上述组合±NIR治疗的组相比,微生物菌落数量显著更低。这些结果表明,RIPND介导的光化学益生菌疗法确实能够迅速抑制皮肤的炎症反应,并在有限使用抗生素的情况下对()提供强大的抗菌作用。综上所述,我们预计RIPND在寻常痤疮的临床治疗中具有很高的应用潜力。